Oncomine Lung CfTNA Cancer Panel
Introduction to the Oncomine Lung CfTNA Cancer Panel
The Oncomine Lung CfTNA Cancer Panel is a revolutionary diagnostic tool that utilizes Next-Generation Sequencing (NGS) technology to analyze genetic mutations in lung cancer patients. This test is essential for understanding the genetic profile of lung tumors, enabling healthcare providers to tailor treatment strategies effectively. With a turnaround time of 2-3 weeks, patients can quickly gain insights into their condition.
What the Test Measures
This panel detects specific genetic mutations related to lung cancer, including alterations in genes such as EGFR, ALK, and KRAS. By identifying these mutations, the Oncomine Lung CfTNA Cancer Panel helps in determining the most effective treatment options available.
Who Should Consider This Test?
Individuals who should consider the Oncomine Lung CfTNA Cancer Panel include:
- Patients diagnosed with lung cancer.
- Individuals experiencing symptoms such as persistent cough, chest pain, or unexplained weight loss.
- Those with a family history of lung cancer or other genetic predispositions.
- Patients seeking personalized treatment plans based on genetic insights.
Benefits of Taking the Test
Taking the Oncomine Lung CfTNA Cancer Panel offers several benefits:
- Early detection of genetic mutations can lead to timely interventions.
- Informed treatment decisions can improve patient outcomes.
- Personalized therapy options based on specific genetic profiles.
- Access to targeted therapies that may not be available without genetic testing.
Understanding Your Results
Once the results are available, our qualified medical professionals will guide you through the interpretation. Understanding your genetic profile is crucial for making informed decisions regarding your treatment path. Results will indicate the presence or absence of specific mutations, which can significantly influence the course of treatment.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 105,000 KSh | 140,000 KSh |
Sample Collection and Pre-Test Instructions
The Oncomine Lung CfTNA Cancer Panel requires a peripheral blood sample (10 ml). It is important to note that this test can only be conducted with a Doctor’s prescription. However, a prescription is not applicable for patients undergoing surgery, those who are pregnant, or individuals planning to travel abroad.
Book Your Test Today!
We have branches across major cities in Kenya, making it convenient for you to access this essential test. For more information or to book the Oncomine Lung CfTNA Cancer Panel, please call or WhatsApp us at +254711564616.
